Procyanidin B2 mitigates methotrexate-induced hepatic pyroptosis by suppressing TLR4/NF-κB and caspase-3/GSDME

Juman Alsaab1, Wedad S Sarawi1, Ahlam M Alhusaini1

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.

Insights

Procyanidin B2 (PCB2) shows protective effects against methotrexate (MTX)-induced liver damage. PCB2 demonstrated antioxidant, anti-inflammatory, and anti-pyroptosis properties, mitigating MTX toxicity in rats.

Area of Science:

  • Hepatology
  • Pharmacology
  • Toxicology

Background:

  • Methotrexate (MTX) is a vital chemotherapeutic and immunosuppressive drug.
  • MTX-induced hepatotoxicity is a significant clinical concern, even at low doses.
  • Understanding protective agents against MTX liver injury is crucial.

Purpose of the Study:

  • To investigate the potential hepatoprotective effects of procyanidin B2 (PCB2) against MTX-induced liver toxicity.
  • To evaluate the impact of PCB2 on oxidative stress, inflammation, and pyroptosis markers in MTX-treated rats.

Main Methods:

  • Rats were treated with PCB2 (40 mg/kg) or quercetin (positive control, 20 mg/kg) followed by MTX (20 mg/kg) injection.
  • Serum transaminases, hepatic oxidative/antioxidant markers (MDA, GSH, SOD), inflammatory cytokines (TNF-α, IL-1β, IL-6), and key protein expressions (NF-κB, TLR4, caspase-3, GSDME) were analyzed.

Main Results:

  • MTX administration significantly elevated serum transaminases, indicating liver injury.
  • MTX induced hepatic oxidative stress, increased inflammatory cytokines, and upregulated NF-κB, TLR4, caspase-3, and GSDME.
  • PCB2 treatment significantly ameliorated MTX-induced hepatotoxicity by restoring oxidant/antioxidant balance and reducing inflammation and pyroptosis markers.

Conclusions:

  • Procyanidin B2 exhibits significant hepatoprotective effects against methotrexate-induced liver injury in rats.
  • PCB2 demonstrates antioxidant, anti-inflammatory, and anti-pyroptosis activities, suggesting its potential therapeutic role.
  • Further research is warranted to confirm PCB2's efficacy as a protective therapy for MTX hepatotoxicity.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
131
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
35
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.0K